Copper and homocysteine in cardiovascular diseases

Pharmacology and Therapeutics

Volumn 129, Issue 3, 2011, Pages 321-331

  Kang, Y James ^a,b  

^a SICHUAN UNIVERSITY   (China)

^b University of Louisville School of Medicine   (United States)

Author keywords

Blood vessel; Ceruloplasmin; Copper; Endothelium; Heart; Homocysteine

Indexed keywords

COPPER; HOMOCYSTEINE;

ANGIOGENESIS; ARTICLE; CARDIOVASCULAR DISEASE; CELL DIFFERENTIATION; CELL PROLIFERATION; CHELATION; COMPLEX FORMATION; COPPER METABOLISM; DIET RESTRICTION; DIETARY INTAKE; ENDOTHELIUM; ENDOTHELIUM CELL; HEART PROTECTION; HUMAN; MICROTUBULE ASSEMBLY; NONHUMAN; OXIDATION REDUCTION REACTION; PATHOGENESIS; PRIORITY JOURNAL; SAPHENOUS VEIN;

EID: 79551681275     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2010.11.004     Document Type: Review

References (118)

1. T.W. Anderson, L.C. Neri, G.B. Schreiber, F.D. Talbot, and A. Zdrojewski Letter: ischemic heart disease, water hardness and myocardial magnesium Can Med Assoc J 113 3 1975 199 203
2. M.D. Apostolova, P.R. Bontchev, B.B. Ivanova, W.R. Russell, D.R. Mehandjiev, and J.H. Beattie Copper-homocysteine complexes and potential physiological actions J Inorg Biochem 95 4 2003 321 333
3. M. Araya, M. Olivares, F. Pizarro, M.A. Mendez, M. Gonzalez, and R. Uauy Supplementing copper at the upper level of the adult dietary recommended intake induces detectable but transient changes in healthy adults J Nutr 135 10 2005 2367 2371
4. M.A. Avila, C. Berasain, J. Prieto, J.M. Mato, E.R. Garcia-Trevijano, and F.J. Corrales Influence of impaired liver methionine metabolism on the development of vascular disease and inflammation Curr Med Chem Cardiovasc Hematol Agents 3 3 2005 267 281
5. Beltowski J. Protein homocysteinylation: a new mechanism of atherogenesis? Postepy Hig Med Dosw (Online) 2005 59392 59404
6. E. Berenshtein, B. Mayer, C. Goldberg, N. Kitrossky, and M. Chevion Patterns of mobilization of copper and iron following myocardial ischemia: possible predictive criteria for tissue injury J Mol Cell Cardiol 29 11 1997 3025 3034
7. Bode A.M., Miller L.A., Faber J., and Saari J.T. Mitochondrial respiration in heart, liver, and kidney of copper-deficiency rats J Nutr Biochem 1992 3668 3672
8. B-Vitamin Treatment Trialists' Collaboration Homocysteine-lowering trials for prevention of cardiovascular events: a review of the design and power of the large randomized trials Am Heart J 151 2 2006 282 287
9. C. Carrasco-Pozo, A. Alvarez-Lueje, C. Olea-Azar, C. Lopez-Alarcon, and H. Speisky In vitro interaction between homocysteine and copper ions: potential redox implications Exp Biol Med (Maywood) 231 9 2006 1569 1575
10. Casey C.E., Guthrie B.E., and Robinson M.F. Copper, manganese, zinc, and cadmium in tissues from New Zealanders Biol Trace Elem Res 1982 4105 4115
11. M. Cesari, G.P. Rossi, and A.C. Pessina Homocysteine-lowering treatment in coronary heart disease Curr Med Chem Cardiovasc Hematol Agents 3 4 2005 289 295
12. M. Cesari, G.P. Rossi, D. Sticchi, and A.C. Pessina Is homocysteine important as risk factor for coronary heart disease? Nutr Metab Cardiovasc Dis 15 2 2005 140 147
13. A. Chatterjee, S.M. Black, and J.D. Catravas Endothelial nitric oxide (NO) and its pathophysiologic regulation Vascul Pharmacol 49 4-6 2008 134 140
14. Z. Cheng, X. Yang, and H. Wang Hyperhomocysteinemia and endothelial dysfunction Curr Hypertens Rev 5 2 2009 158 165
15. M. Chevion, Y. Jiang, R. Har-El, E. Berenshtein, G. Uretzky, and N. Kitrossky Copper and iron are mobilized following myocardial ischemia: possible predictive criteria for tissue injury Proc Natl Acad Sci USA 90 3 1993 1102 1106
16. B. Chipperfield, and J.R. Chipperfield Differences in metal content of the heart muscle in death from ischemic heart disease Am Heart J 95 6 1978 732 737
17. R. Clarke Homocysteine-lowering trials for prevention of heart disease and stroke Semin Vasc Med 5 2 2005 215 222
18. R. Clarke, and S. Lewington Homocysteine and coronary heart disease Semin Vasc Med 2 4 2002 391 399
19. G.J. Cooper, Y.K. Chan, A.M. Dissanayake, F.E. Leahy, G.F. Keogh, and C.M. Frampton Demonstration of a hyperglycemia-driven pathogenic abnormality of copper homeostasis in diabetes and its reversibility by selective chelation: quantitative comparisons between the biology of copper and eight other nutritionally essential elements in normal and diabetic individuals Diabetes 54 5 2005 1468 1476
20. G.J. Cooper, A.R. Phillips, S.Y. Choong, B.L. Leonard, D.J. Crossman, and D.H. Brunton Regeneration of the heart in diabetes by selective copper chelation Diabetes 53 9 2004 2501 2508
21. S. Dayal, and S.R. Lentz ADMA and hyperhomocysteinemia Vasc Med 10 Suppl 1 2005 S27 S33
22. S.P. Duckles, and V.M. Miller Hormonal modulation of endothelial NO production Pflugers Arch 459 6 2010 841 851
23. N.P. Dudman, and D.E. Wilcken Increased plasma copper in patients with homocystinuria due to cystathionine beta-synthase deficiency Clin Chim Acta 127 1 1983 105 113
24. L. Elsherif, R.V. Ortines, J.T. Saari, and Y.J. Kang Congestive heart failure in copper-deficient mice Exp Biol Med (Maywood) 228 7 2003 811 817
25. L. Elsherif, L. Wang, J.T. Saari, and Y.J. Kang Regression of dietary copper restriction-induced cardiomyopathy by copper repletion in mice J Nutr 134 4 2004 855 860 (Pubitemid 38456254)
26. A.M. Emsley, J.Y. Jeremy, G.N. Gomes, G.D. Angelini, and F. Plane Investigation of the inhibitory effects of homocysteine and copper on nitric oxide-mediated relaxation of rat isolated aorta Br J Pharmacol 126 4 1999 1034 1040
27. M. Exner, M. Hermann, R. Hofbauer, B. Hartmann, S. Kapiotis, and B. Gmeiner Homocysteine promotes the LDL oxidase activity of ceruloplasmin FEBS Lett 531 3 2002 402 406
28. Falcone J.C., Saari J.T., Kang Y.J., and Schuschke D.A. Vasoreactivity in an adult rat model of marginal copper deficiency Nutr Res 2005 25177 25186
29. W. Feng, F. Ye, W. Xue, Z. Zhou, and Y.J. Kang Copper regulation of hypoxia-inducible factor-1 activity Mol Pharmacol 75 1 2009 174 182
30. D. Ferechide, and D. Radulescu Hyperhomocysteinemia in renal diseases J Med Life 2 1 2009 53 59
31. E.S. Ford Serum copper concentration and coronary heart disease among US adults Am J Epidemiol 151 12 2000 1182 1188
32. P. Freisinger, R. Horvath, C. Macmillan, J. Peters, and M. Jaksch Reversion of hypertrophic cardiomyopathy in a patient with deficiency of the mitochondrial copper binding protein Sco2: is there a potential effect of copper? J Inherit Metab Dis 27 1 2004 67 79
33. L.M. Gaetke, and C.K. Chow Copper toxicity, oxidative stress, and antioxidant nutrients Toxicology 189 1-2 2003 147 163
34. C.M. Galhardi, Y.S. Diniz, L.A. Faine, H.G. Rodrigues, R.C. Burneiko, and B.O. Ribas Toxicity of copper intake: lipid profile, oxidative stress and susceptibility to renal dysfunction Food Chem Toxicol 42 12 2004 2053 2060
35. J. Garthwaite New insight into the functioning of nitric oxide-receptive guanylyl cyclase: physiological and pharmacological implications Mol Cell Biochem 334 1-2 2010 221 232
36. J.R. Goodman, J.B. Warshaw, and P.R. Dallman Cardiac hypertrophy in rats with iron and copper deficiency: quantitative contribution of mitochondrial enlargement Pediatr Res 4 3 1970 244 256
37. B. Halvorsen, I. Brude, C.A. Drevon, J. Nysom, L. Ose, and E.N. Christiansen Effect of homocysteine on copper ion-catalyzed, azo compound-initiated, and mononuclear cell-mediated oxidative modification of low density lipoprotein J Lipid Res 37 7 1996 1591 1600
38. Hellman N.E., and Gitlin J.D. Ceruloplasmin metabolism and function Annu Rev Nutr 2002 22439 22458
39. D. Horn, and A. Barrientos Mitochondrial copper metabolism and delivery to cytochrome c oxidase IUBMB Life 60 7 2008 421 429
40. G.F. Hu Copper stimulates proliferation of human endothelial cells under culture J Cell Biochem 69 3 1998 326 335
41. J. Hulthe Antibodies to oxidized LDL in atherosclerosis development-clinical and animal studies Clin Chim Acta 348 1-2 2004 1 8
42. V.K. Jain, and G. Mohan Serum zinc and copper in myocardial infarction with particular reference to prognosis Biol Trace Elem Res 31 3 1991 317 322
43. M. Jaksch, I. Ogilvie, J. Yao, G. Kortenhaus, H.G. Bresser, and K.D. Gerbitz Mutations in SCO2 are associated with a distinct form of hypertrophic cardiomyopathy and cytochrome c oxidase deficiency Hum Mol Genet 9 5 2000 795 801
44. H. Jakubowski Protein homocysteinylation: possible mechanism underlying pathological consequences of elevated homocysteine levels FASEB J 13 15 1999 2277 2283
45. H. Jakubowski Calcium-dependent human serum homocysteine thiolactone hydrolase. A protective mechanism against protein N-homocysteinylation J Biol Chem 275 6 2000 3957 3962
46. H. Jakubowski Homocysteine-thiolactone and S-nitroso-homocysteine mediate incorporation of homocysteine into protein in humans Clin Chem Lab Med 41 11 2003 1462 1466
47. H. Jakubowski, L. Zhang, A. Bardeguez, and A. Aviv Homocysteine thiolactone and protein homocysteinylation in human endothelial cells: implications for atherosclerosis Circ Res 87 1 2000 45 51
48. J.Y. Jeremy, N. Shukla, G.D. Angelini, A. Day, I.Y. Wan, and S.P. Talpahewa Sustained increases of plasma homocysteine, copper, and serum ceruloplasmin after coronary artery bypass grafting Ann Thorac Surg 74 5 2002 1553 1557
49. Y. Jiang, C. Reynolds, C. Xiao, W. Feng, Z. Zhou, and W. Rodriguez Dietary copper supplementation reverses hypertrophic cardiomyopathy induced by chronic pressure overload in mice J Exp Med 204 3 2007 657 666
50. W.T. Johnson, and A.C. Thomas Copper deprivation potentiates oxidative stress in HL-60 cell mitochondria Proc Soc Exp Biol Med 221 2 1999 147 152
51. E.L. Kanabrocki, L.F. Case, L. Graham, T. Fields, E.B. Miller, and Y.T. Oester Non-dialyzable manganese and copper levels in serum of patients with various diseases J Nucl Med 8 3 1967 166 172
52. Y.J. Kang, H. Wu, and J.T. Saari Alterations in hypertrophic gene expression by dietary copper restriction in mouse heart Proc Soc Exp Biol Med 223 3 2000 282 287
53. Y.J. Kang, Z.X. Zhou, H. Wu, G.W. Wang, J.T. Saari, and J.B. Klein Metallothionein inhibits myocardial apoptosis in copper-deficient mice: role of atrial natriuretic peptide Lab Invest 80 5 2000 745 757
54. M.A. Khan, C.S. Thompson, A.M. Emsley, F.H. Mumtaz, D.P. Mikhailidis, and G.D. Angelini The interaction of homocysteine and copper markedly inhibits the relaxation of rabbit corpus cavernosum: new risk factors for angiopathic erectile dysfunction? BJU Int 84 6 1999 720 724
55. B.E. Kim, T. Nevitt, and D.J. Thiele Mechanisms for copper acquisition, distribution and regulation Nat Chem Biol 4 3 2008 176 185
56. G.D. Kinsman, A.N. Howard, D.L. Stone, and P.A. Mullins Studies in copper status and atherosclerosis Biochem Soc Trans 18 6 1990 1186 1188
57. L.M. Klevay, and D.M. Medeiros Deliberations and evaluations of the approaches, endpoints and paradigms for dietary recommendations about copper J Nutr 126 9 Suppl 1996 2419S 2426S
58. F.J. Kok, C.M. Van Duijn, A. Hofman, G.B. Van der Voet, F.A. De Wolff, and C.H. Paays Serum copper and zinc and the risk of death from cancer and cardiovascular disease Am J Epidemiol 128 2 1988 352 359
59. S.J. Kopp, L.M. Klevay, and J.M. Feliksik Physiological and metabolic characterization of a cardiomyopathy induced by chronic copper deficiency Am J Physiol 245 5 Pt 1 1983 H855 H866
60. A.J. Koupparis, J. Jeremy, G. Angelini, R. Persad, and N. Shukla Penicillamine administration reverses the inhibitory effect of hyperhomocysteinaemia on endothelium-dependent relaxation in the corpus cavernosum in the rabbit BJU Int 98 2 2006 440 444
61. D.J. Lamb, M.L. Tickner, S.M. Hourani, and G.A. Ferns Dietary copper supplements modulate aortic superoxide dismutase, nitric oxide and atherosclerosis Int J Exp Pathol 86 4 2005 247 255
62. A. Le Bras, P. Vijayaraj, and P. Oettgen Molecular mechanisms of endothelial differentiation Vasc Med 15 2010 321 331
63. S.R. Lentz Mechanisms of homocysteine-induced atherothrombosis J Thromb Haemost 3 8 2005 1646 1654
64. S.R. Lentz, C.G. Sobey, D.J. Piegors, M.Y. Bhopatkar, F.M. Faraci, and M.R. Malinow Vascular dysfunction in monkeys with diet-induced hyperhomocyst(e)inemia J Clin Invest 98 1 1996 24 29
65. Y. Li, L. Wang, D.A. Schuschke, Z. Zhou, J.T. Saari, and Y.J. Kang Marginal dietary copper restriction induces cardiomyopathy in rats J Nutr 135 9 2005 2130 2136
66. M. Linnebank, H. Lutz, E. Jarre, S. Vielhaber, C. Noelker, and E. Struys Binding of copper is a mechanism of homocysteine toxicity leading to COX deficiency and apoptosis in primary neurons, PC12 and SHSY-5Y cells Neurobiol Dis 23 3 2006 725 730
67. S.O. Loureiro, L. Romao, T. Alves, A. Fonseca, L. Heimfarth, and V.M. Neto Homocysteine induces cytoskeletal remodeling and production of reactive oxygen species in cultured cortical astrocytes Brain Res 1355 2010 151 164
68. C.M. Mak, and C.W. Lam Diagnosis of Wilson's disease: a comprehensive review Crit Rev Clin Lab Sci 45 3 2008 263 290
69. M.R. Malinow, A.G. Bostom, and R.M. Krauss Homocyst(e)ine, diet, and cardiovascular diseases: a statement for healthcare professionals from the Nutrition Committee, American Heart Association Circulation 99 1 1999 178 182
70. D.L. Mann Mechanisms and models in heart failure: a combinatorial approach Circulation 100 9 1999 999 1008
71. M.A. Mansoor, C. Bergmark, S.J. Haswell, I.F. Savage, P.H. Evans, and R.K. Berge Correlation between plasma total homocysteine and copper in patients with peripheral vascular disease Clin Chem 46 3 2000 385 391
72. F. Martin, T. Linden, D.M. Katschinski, F. Oehme, I. Flamme, and C.K. Mukhopadhyay Copper-dependent activation of hypoxia-inducible factor (HIF)-1: implications for ceruloplasmin regulation Blood 105 12 2005 4613 4619
73. B.J. Martin, T.D. Lyon, and G.S. Fell Comparison of inorganic elements from autopsy tissue of young and elderly subjects J Trace Elem Electrolytes Health Dis 5 3 1991 203 211
74. K.S. McCully Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis Am J Pathol 56 1 1969 111 128
75. D.M. Medeiros, D. Bagby, G. Ovecka, and R. McCormick Myofibrillar, mitochondrial and valvular morphological alterations in cardiac hypertrophy among copper-deficient rats J Nutr 121 6 1991 815 824
76. D.M. Medeiros, J. Davidson, and J.E. Jenkins A unified perspective on copper deficiency and cardiomyopathy Proc Soc Exp Biol Med 203 3 1993 262 273
77. D.M. Medeiros, and R.E. Wildman Newer findings on a unified perspective of copper restriction and cardiomyopathy Proc Soc Exp Biol Med 215 4 1997 299 313
78. R. Misra, S.A. Bhambal, N.P. Misra, and S.M. Misra Serum copper, ceruloplasmin & iron in ischaemic heart disease Indian Heart J 30 6 1978 339 344
79. E. Nakano, M.P. Williamson, N.H. Williams, and H.J. Powers Copper-mediated LDL oxidation by homocysteine and related compounds depends largely on copper ligation Biochim Biophys Acta 1688 1 2004 33 42
80. Niskanen J., Marniemi J., Piironen O., Maatela J., Maki J., and Vuori I. Trace element levels in serum and urine of subjects died of coronary heart disease Acta Pharmacol Toxicol (Copenh) 59 Suppl 1986 7,340 7,343
81. L.C. Papadopoulou, C.M. Sue, M.M. Davidson, K. Tanji, I. Nishino, and J.E. Sadlock Fatal infantile cardioencephalomyopathy with COX deficiency and mutations in SCO2, a COX assembly gene Nat Genet 23 3 1999 333 337
82. J.R. Prohaska Biochemical changes in copper deficiency J Nutr Biochem 1 1990 452 461
83. J.R. Prohaska, and L.J. Heller Mechanical properties of the copper-deficient rat heart J Nutr 112 11 1982 2142 2150
84. T.D. Rae, P.J. Schmidt, R.A. Pufahl, V.C. Culotta, and T.V. O'Halloran Undetectable intracellular free copper: the requirement of a copper chaperone for superoxide dismutase Science 284 1999 805 808
85. R. Rajendran, M. Ren, P. Ning, H.B. Tan Kwong, B. Halliwell, and F. Watt Promotion of atherogenesis by copper or iron-which is more likely? Biochem Biophys Res Commun 353 1 2007 6 10
86. S. Reiser, J.C. Smith Jr., W. Mertz, J.T. Holbrook, D.J. Scholfield, and A.S. Powell Indices of copper status in humans consuming a typical American diet containing either fructose or starch Am J Clin Nutr 42 2 1985 242 251 (Pubitemid 16246355)
87. A. Reunanen, P. Knekt, and R.K. Aaran Serum ceruloplasmin level and the risk of myocardial infarction and stroke Am J Epidemiol 136 9 1992 1082 1090
88. J.T. Saari Copper deficiency and cardiovascular disease: role of peroxidation, glycation, and nitration Can J Physiol Pharmacol 78 10 2000 848 855
89. J.T. Salonen, R. Salonen, H. Korpela, S. Suntioinen, and J. Tuomilehto Serum copper and the risk of acute myocardial infarction: a prospective population study in men in eastern Finland Am J Epidemiol 134 3 1991 268 276
90. L. Salviati, E. Hernandez-Rosa, W.F. Walker, S. Sacconi, S. DiMauro, and E.A. Schon Copper supplementation restores cytochrome c oxidase activity in cultured cells from patients with SCO2 mutations Biochem J 363 Pt 2 2002 321 327
91. H.A. Schroeder, A.P. Nason, I.H. Tipton, and J.J. Balassa Essential trace metals in man: copper J Chron Dis 19 9 1966 1007 1034
92. J. Selhub The many facets of hyperhomocysteinemia: studies from the Framingham cohorts J Nutr 136 6 Suppl 2006 1726S 1730S
93. N. Shukla, G.D. Angelini, and J.Y. Jeremy Interactive effects of homocysteine and copper on angiogenesis in porcine isolated saphenous vein Ann Thorac Surg 84 1 2007 43 49
94. N. Shukla, A. Koupparis, R.A. Jones, G.D. Angelini, R. Persad, and J.Y. Jeremy Penicillamine administration reverses the inhibitory effect of hyperhomocysteinaemia on endothelium-dependent relaxation and superoxide formation in the aorta of the rabbit Eur J Pharmacol 531 1-3 2006 201 208
95. R.B. Singh, U.C. Gupta, N. Mittal, M.A. Niaz, S. Ghosh, and V. Rastogi Epidemiologic study of trace elements and magnesium on risk of coronary artery disease in rural and urban Indian populations J Am Coll Nutr 16 1 1997 62 67 (Pubitemid 27073676)
96. M.M. Singh, R. Singh, A. Khare, M.C. Gupta, N.L. Patney, and V.K. Jain Serum copper in myocardial infarction-diagnostic and prognostic significance Angiology 36 8 1985 504 510
97. Y. Song, J. Wang, Y. Li, Y. Du, G.E. Arteel, and J.T. Saari Cardiac metallothionein synthesis in streptozotocin-induced diabetic mice, and its protection against diabetes-induced cardiac injury Am J Pathol 167 1 2005 17 26
98. K.T. Suzuki, A. Someya, Y. Komada, and Y. Ogra Roles of metallothionein in copper homeostasis: responses to Cu-deficient diets in mice J Inorg Biochem 88 2 2002 173 182
99. T. Tamura, and J.R. Turnlund Effect of long-term, high-copper intake on the concentrations of plasma homocysteine and B vitamins in young men Nutrition 20 9 2004 757 759
100. H. Tapiero, D.M. Townsend, and K.D. Tew Trace elements in human physiology and pathology. Copper Biomed Pharmacother 57 9 2003 386 398
101. G.O. Taylor, and A.O. Williams Lipid and trace metal content in coronary arteries of Nigerian Africans Exp Mol Pathol 21 3 1974 371 380
102. G. Topal, A. Brunet, E. Millanvoye, J.L. Boucher, F. Rendu, and M.A. Devynck Homocysteine induces oxidative stress by uncoupling of NO synthase activity through reduction of tetrahydrobiopterin Free Radic Biol Med 36 12 2004 1532 1541
103. P. Trumbo, A.A. Yates, S. Schlicker, and M. Poos Dietary reference intakes: vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc J Am Diet Assoc 101 3 2001 294 301
104. C.M. Tsen, C.C. Hsieh, C.H. Yen, and Y.T. Lau Homocysteine altered ROS generation and NO accumulation in endothelial cells Chin J Physiol 46 3 2003 129 136
105. B. Turczyn, and A. Skoczynska Antiatherogenic effect of high density lipoprotein Postepy Hig Med Dosw 56 4 2002 499 520
106. J.B. Ubbink, A. van der Merwe, R. Delport, R.H. Allen, S.P. Stabler, and R. Riezler The effect of a subnormal vitamin B-6 status on homocysteine metabolism J Clin Invest 98 1 1996 177 184
107. A. Undas, J. Perla, M. Lacinski, W. Trzeciak, R. Kazmierski, and H. Jakubowski Autoantibodies against N-homocysteinylated proteins in humans: implications for atherosclerosis Stroke 35 6 2004 1299 1304
108. K. Vesela, H. Hansikova, M. Tesarova, P. Martasek, M. Elleder, and J. Houstek Clinical, biochemical and molecular analyses of six patients with isolated cytochrome c oxidase deficiency due to mutations in the SCO2 gene Acta Paediatr 93 10 2004 1312 1317
109. K.E. Viestenz, and L.M. Klevay A randomized trial of copper therapy in rats with electrocardiographic abnormalities due to copper deficiency Am J Clin Nutr 35 2 1982 258 266
110. A. Vignini, L. Nanetti, T. Bacchetti, G. Ferretti, G. Curatola, and L. Mazzanti Modification induced by homocysteine and low-density lipoprotein on human aortic endothelial cells: an in vitro study J Clin Endocrinol Metab 89 9 2004 4558 4561
111. P.O. Wester Trace elements in human myocardial infarction determined by neutron activation analysis Acta Med Scand 178 6 1965 765 788
112. A.R. White, X. Huang, M.F. Jobling, C.J. Barrow, K. Beyreuther, and C.L. Masters Homocysteine potentiates copper- and amyloid beta peptide-mediated toxicity in primary neuronal cultures: possible risk factors in the Alzheimer's-type neurodegenerative pathways J Neurochem 76 5 2001 1509 1520
113. D.M. Williams, and C.L. Atkin Tissue copper concentrations of patients with Menke's kinky hair disease Am J Dis Child 135 4 1981 375 376
114. J.C. Yarze, P. Martin, S.J. Munoz, and L.S. Friedman Wilson's disease: current status Am J Med 92 6 1992 643 654
115. N. Zama, and R.L.R. Towns Cardiac copper, magnesium, and zinc in recent and old myocardial infarction Biol Trace Elem Res 10 1986 201 208
116. Z. Zhou, W.T. Johnson, and Y.J. Kang Regression of copper-deficient heart hypertrophy: reduction in the size of hypertrophic cardiomyocytes J Nutr Biochem 20 8 2009 621 628
117. A. Zinellu, S. Sotgia, B. Scanu, G. Pintus, A.M. Posadino, and A. Cossu S-homocysteinylated LDL apolipoprotein B adversely affects human endothelial cells in vitro Atherosclerosis 206 1 2009 40 46
118. C.G. Zou, and R. Banerjee Homocysteine and redox signaling Antioxid Redox Signal 7 5-6 2005 547 559